FDA Inspection
HP Halden Pharma ASHP Halden Pharma AS – FDA Inspection, Sep 3, 2019
Record Details
This FDA Inspection record concerns HP Halden Pharma AS, with an inspection on September 3, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9cb54f53-5d4e-4f5c-93a1-2c26eeb75e27
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1101303
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of HP Halden Pharma AS
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for HP Halden Pharma AS
- FDA Inspection 1205610 - 2023-05-10
- FDA Inspection 1014636 - 2017-05-26
- FDA Inspection 931958 - 2015-06-26
- FDA Inspection 863615 - 2013-12-20
- FDA Inspection 797565 - 2012-08-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.